Report Categories
View AllRecent Articles
View All
IMMP Immutep shares drop 565 after Q1 2026 EPS posts wider than expected quarterly loss
How BioLineRx BLRX balances growth with profitability Strengthens 20260503
QTTB Q32 Bio posts massive Q4 2025 EPS beat but shares drop 385 percent amid investor uncertainty
EW SSP Competitive Edge EW delivers 139 percent EPS beat topping analyst estimates